Theravectys Company
Theravectys develops a platform for the prevention and treatment of cancers and other infectious diseases and conditions.
Technology:
Viral Vectors
Headquarters:
Paris, Ile-de-France, France
Founded Date:
2005-01-01
Employees Number:
1-10
Investors Number:
6
Total Funding:
6784401
Estimated Revenue:
$10M to $50M
Last Funding Date:
2021-02-08
Last Funding Type:
Venture - Series Unknown
Register and Claim Ownership